- Home
- EMD vs PSNL Comparison
EMD vs PSNL Comparison
Compare EMD & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMD
- PSNL
- Stock Information
- Founded
- EMD 2003
- PSNL 2011
- Country
- EMD United States
- PSNL United States
- Employees
- EMD N/A
- PSNL N/A
- Industry
- EMD Finance/Investors Services
- PSNL Medical Specialities
- Sector
- EMD Finance
- PSNL Health Care
- Exchange
- EMD Nasdaq
- PSNL Nasdaq
- Market Cap
- EMD 581.9M
- PSNL 562.6M
- IPO Year
- EMD N/A
- PSNL 2019
- Fundamental
- Price
- EMD $10.10
- PSNL $5.59
- Analyst Decision
- EMD
- PSNL Strong Buy
- Analyst Count
- EMD 0
- PSNL 5
- Target Price
- EMD N/A
- PSNL $8.00
- AVG Volume (30 Days)
- EMD 248.5K
- PSNL 1.1M
- Earning Date
- EMD 01-01-0001
- PSNL 08-05-2025
- Dividend Yield
- EMD 10.25%
- PSNL N/A
- EPS Growth
- EMD N/A
- PSNL N/A
- EPS
- EMD N/A
- PSNL N/A
- Revenue
- EMD N/A
- PSNL $85,694,000.00
- Revenue This Year
- EMD N/A
- PSNL $0.45
- Revenue Next Year
- EMD N/A
- PSNL $25.75
- P/E Ratio
- EMD N/A
- PSNL N/A
- Revenue Growth
- EMD N/A
- PSNL 15.57
- 52 Week Low
- EMD $7.85
- PSNL $2.81
- 52 Week High
- EMD $9.55
- PSNL $7.79
- Technical
- Relative Strength Index (RSI)
- EMD 54.25
- PSNL 39.04
- Support Level
- EMD $10.00
- PSNL $6.09
- Resistance Level
- EMD $10.13
- PSNL $6.94
- Average True Range (ATR)
- EMD 0.07
- PSNL 0.38
- MACD
- EMD -0.02
- PSNL -0.15
- Stochastic Oscillator
- EMD 45.45
- PSNL 6.25
About EMD Western Asset Emerging Markets Debt Fund Inc
Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management, and long term investment company. The primary investment objective of the company is to seek high current income and the secondary objective is to seek capital appreciation.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.